MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 11, 2005; DOI: 10.1124/mol.105.014886


0026-895X/05/6805-1387-1396$20.00
Mol Pharmacol 68:1387-1396, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.014886v1
68/5/1387    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lechner, S. G.
Right arrow Articles by Boehm, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lechner, S. G.
Right arrow Articles by Boehm, S.

Presynaptic Inhibition via a Phospholipase C- and Phosphatidylinositol Bisphosphate-Dependent Regulation of Neuronal Ca2+ Channels

Stefan G. Lechner, Simon Hussl, Klaus W. Schicker, Helmut Drobny, and Stefan Boehm

Department of Pharmacology, Center of Biomolecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria

Presynaptic inhibition of transmitter release is commonly mediated by a direct interaction between G protein {beta}{gamma} subunits and voltage-activated Ca2+ channels. To search for an alternative pathway, the mechanisms by which presynaptic bradykinin receptors mediate an inhibition of noradrenaline release from rat superior cervical ganglion neurons were investigated. The peptide reduced noradrenaline release triggered by K+-depolarization but not that evoked by ATP, with Ca2+ channels being blocked by Cd2+. Bradykinin also reduced Ca2+ current amplitudes measured at neuronal somata, and this effect was pertussis toxin-insensitive, voltage-independent, and developed slowly within 1 min. The inhibition of Ca2+ currents was abolished by a phospholipase C inhibitor, but it was not altered by a phospholipase A2 inhibitor, by the depletion of intracellular Ca2+ stores, or by the inactivation of protein kinase C or Rho proteins. In whole-cell recordings, the reduction of Ca2+ currents was irreversible but became reversible when 4 mM ATP or 0.2 mM dioctanoyl phosphatidylinositol-4,5-bisphosphate was included in the pipette solution. In contrast, the effect of bradykinin was entirely reversible in perforated-patch recordings but became irreversible when the resynthesis of phosphatidylinositol-4,5-bisphosphate was blocked. Thus, the inhibition of Ca2+ currents by bradykinin involved a consumption of phosphatidylinositol-4,5-bisphosphate by phospholipase C but no downstream effectors of this enzyme. The reduction of noradrenaline release by bradykinin was also abolished by the inhibition of phospholipase C or of the resynthesis of phosphatidylinositol-4,5-bisphosphate. These results show that the presynaptic inhibition was mediated by a closure of voltage-gated Ca2+ channels through depletion of membrane phosphatidylinositol bisphosphates via phospholipase C.


Received May 19, 2005; accepted August 10, 2005

Address correspondence to: Dr. Stefan Boehm, Department of Pharmacology, Center of Biomolecular, Medicine and Pharmacology, Medical University of Vienna, Waehringerstrasse 13a, A-1090 Vienna, Austria. E-mail: Stefan.Boehm{at}meduniwien.ac.at




This article has been cited by other articles:


Home page
J. Physiol.Home page
N. Gamper and M. S. Shapiro
Reply from N. Gamper and M. S. Shapiro
J. Physiol., September 15, 2007; 583(3): 1167 - 1167.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
O. Zaika, G. P. Tolstykh, D. B. Jaffe, and M. S. Shapiro
Inositol Triphosphate-Mediated Ca2+ Signals Direct Purinergic P2Y Receptor Regulation of Neuronal Ion Channels
J. Neurosci., August 15, 2007; 27(33): 8914 - 8926.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Gamper and M. S. Shapiro
Target-specific PIP2 signalling: how might it work?
J. Physiol., August 1, 2007; 582(3): 967 - 975.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Gambino, A. Pavlowsky, A. Begle, J.-L. Dupont, N. Bahi, R. Courjaret, R. Gardette, H. Hadjkacem, H. Skala, B. Poulain, et al.
IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation
PNAS, May 22, 2007; 104(21): 9063 - 9068.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics